When policy meets practice - the problems of 'mode 2' initiatives in the translation of academic knowledge
暂无分享,去创建一个
Sue Newell | Maxine Robertson | Jacky Swan | Mike Bresnen | Sue Dopson | S. Newell | J. Swan | M. Robertson | S. Dopson | Mike Bresnen
[1] Diana Hicks,et al. Science policy for a highly collaborative science system , 1996 .
[2] Nader A. Salman,et al. Indirect Networks: An Intangible Resource for Biotechnology Innovation , 2005 .
[3] David Tranfield,et al. Formulating the Nature of Management Research , 2002 .
[4] E. Ferlie,et al. The Nonspread of Innovations: the Mediating Role of Professionals , 2005 .
[5] Jacky Swan,et al. The politics of networked innovation , 2005 .
[6] D. Maclean,et al. Mode 2 Management Research , 2002 .
[7] J. Aken. Management Research as a Design Science: Articulating the Research Products of Mode 2 Knowledge Production in Management , 2005 .
[8] Sue Dopson,et al. The Diffusion of Medical Innovations: Can Figurational Sociology Contribute? , 2005 .
[9] C. Hardy. Understanding Power: Bringing about Strategic Change , 1996 .
[10] K. Knorr-Cetina,et al. Epistemic cultures : how the sciences make knowledge , 1999 .
[11] A. Huff,et al. Re‐Focusing the Business School Agenda , 2001 .
[12] B. Salter,et al. Change in the policy community of human genetics: a pragmatic approach to open governance , 2006 .
[13] Ken Starkey,et al. Bridging the Relevance Gap: Aligning Stakeholders in the Future of Management Research , 2001 .
[14] Maxine Robertson,et al. Translating Breakthroughs in Genetics into Biomedical Innovation: The Case of UK Genetic Knowledge Parks , 2007, Technol. Anal. Strateg. Manag..
[15] Arie Rip,et al. Regional Innovation Systems and the Advent of Strategic Science , 2002 .
[16] D. Bell. The Coming of the Post-Industrial Society , 1973 .
[17] Andrew Pettigrew,et al. The determinants of research group performance: Towards Mode 2? , 2002 .
[18] R. Rothwell. Towards the Fifth‐generation Innovation Process , 1994 .
[19] Sue Newell,et al. Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities , 2007 .
[20] Deborah Dougherty. Trapped in the 20th Century? Why Models of Organizational Learning, Knowledge and Capabilities Do Not Fit Bio-pharmaceuticals, and What to Do About That , 2007 .
[21] W. Powell,et al. Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology. , 1996 .
[22] Walter W. Powell,et al. Knowledge Networks as Channels and Conduits: The Effects of Spillovers in the Boston Biotechnology Community , 2004, Organ. Sci..
[23] A. V. D. Ven,et al. Knowledge for Theory and Practice , 2006 .
[24] B. Latour. From the World of Science to the World of Research? , 1998, Science.
[25] G. Pisano. Can science be a business? Lessons from biotech. , 2006, Harvard business review.
[26] Rebecca Henderson,et al. Sources of Industrial Leadership: The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change , 1999 .
[27] Daniele Archibugi,et al. International partnerships for knowledge in business and academia: A comparison between Europe and the USA , 2004 .
[28] Paul R. Carlile,et al. Transferring, Translating, and Transforming: An Integrative Framework for Managing Knowledge Across Boundaries , 2004, Organ. Sci..
[29] B. Salter,et al. The governance of human genetics: Policy discourse and constructions of public trust , 2003, New genetics and society.
[30] M. Gibbons,et al. Re-Thinking Science: Knowledge and the Public in an Age of Uncertainty , 2003 .